Scientific article
OA Policy
English

Association of NUDT15*3 and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia

Published in

Genes, vol. 11, no. 6, 594

Publication date

2020

Abstract

Genetic variants influencing the pharmacokinetics and/or pharmacodynamics of the chemotherapeutic drugs used in Acute Lymphoblastic Leukemia (ALL) therapy often contribute to the occurrence of treatment related toxicity (TRT). In this study, we explored the association of candidate genetic variants with early hematological TRT (grade 3-4) occurring within the first 100 days of low-dose methotrexate and 6-mercaptopurine based maintenance therapy (n = 73). Fourteen variants in the following candidate genes were genotyped using allele discrimination assay by real-time PCR: ABCB1, DHFR, GGH, FPGS, MTHFR, RFC1, SLCO1B1, TPMT, and NUDT15. Methotrexate polyglutamate (MTXPG3-5) levels in red blood cells were measured by LC-MS/MS. Early hematological TRT (grade 3-4) was seen in 54.9% of patients. The NUDT15*3 allele was associated with early TRT occurrence [HR: 3.04 (95% CI: 1.5-6.1); p = 0.007]. Sensitivity of early TRT prediction improved (from 30.7% to 89.7%) by considering FPGS variant (rs1544105) carrier status along with NUDT15*3 allele [HR = 2.7 (1.5-4.7, p = 0.008)]. None of the considered genetic variants were associated with MTXPG3-5 levels, which in turn were not associated with early TRT. NUDT15*3 allele carrier status could be used as a stratifying marker for Indian ALL patients to distinguish patients at high or low risk of developing early hematological TRT.

Keywords

  • 6-mercaptopurine
  • India
  • NUDT15
  • Acute lymphoblastic leukemia
  • Children
  • Methotrexate
  • Myelosuppression
  • Polymorphism
  • Relapse
  • Survival
  • Toxicity

Citation (ISO format)

KODIDELA, Sunitha et al. Association of NUDT15*3 and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia. In: Genes, 2020, vol. 11, n° 6, p. 594. doi: 10.3390/genes11060594

Main files (1)

Article (Published version)

Secondary files (1)

Appendix

Identifiers

Additional URL for this publication

https://www.mdpi.com/2073-4425/11/6/594

Journal ISSN

2073-4425
271views
265downloads

Technical informations

Creation

16/02/2021 15:52:00

First validation

16/02/2021 15:52:00

Update

16/03/2023 00:18:26

Status update

16/03/2023 00:18:25

Last indexation

31/10/2024 21:41:22
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated